Plain-English translation of NCT07236177 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is a pilot study testing a brand-new way to detect cancer early using a simple blood test. Instead of looking for cancer cells directly, researchers measure special enzymes in your blood plasma that may signal the presence of cancer. The study will enroll people with three types of localized cancer (breast, lung, and pancreas) as well as healthy people without cancer, to see if this enzyme-based approach can reliably tell the difference.
Current cancer detection methods often require invasive procedures or are not available early enough to catch cancer when it is most treatable. This new blood test aims to provide a non-invasive, simple way to detect cancer earlier and help guide treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you are in a cancer group, you will have two small blood samples taken (about 5 milliliters each—roughly a teaspoon)—one before your scheduled surgery and one after. If you are in the healthy control group, you will have just one blood sample taken. The blood will be analyzed using special tests to measure enzyme activity. The entire process is non-invasive and takes only a few minutes per visit.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France